Schöning, Verena

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2023 | 2022 | 2021


Drewe, Jürgen; Schöning, Verena; Danton, Ombeline; Schenk, Alexander; Boonen, Georg (2024). Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa as Critical Mediators of AMPK Activation. Pharmaceutics, 16(4) MDPI 10.3390/pharmaceutics16040511


Schöning, Verena; Khurana, Amit; Karolak, Aleksandra (2023). Editorial: Spotlight on artificial intelligence in experimental pharmacology and drug discovery. Frontiers in Pharmacology, 14, p. 1261141. Frontiers 10.3389/fphar.2023.1261141


Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K; Hautz, Wolf E; Atkinson, Andrew; Hammann, Felix (2022). Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern. Journal of translational medicine, 20(1), p. 427. BioMed Central 10.1186/s12967-022-03634-x

Schöning, Verena; Hammann, Felix (2022). Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients. Pharmaceutics, 14(9) MDPI 10.3390/pharmaceutics14091828

Schöning, Verena; Kern, Charlotte; Chaccour, Carlos; Hammann, Felix (2022). Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study. Frontiers in Pharmacology, 13, p. 816429. Frontiers 10.3389/fphar.2022.816429


Drewe, Jürgen; Küsters, Ernst; Hammann, Felix; Kreuter, Matthias; Boss, Philipp; Schöning, Verena (2021). Modeling Structure-Activity Relationship of AMPK Activation. Molecules, 26(21) Molecular Diversity Preservation International MDPI 10.3390/molecules26216508

Schöning, Verena; Liakoni, Evangelia; Baumgartner, Christine; Exadaktylos, Aristomenis K.; Hautz, Wolf E.; Atkinson, Andrew; Hammann, Felix (2021). Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital. Journal of translational medicine, 19(1), p. 56. BioMed Central 10.1186/s12967-021-02720-w

Chaccour, Carlos; Casellas, Aina; Blanco-Di Matteo, Andrés; Pineda, Iñigo; Fernandez-Montero, Alejandro; Ruiz-Castillo, Paula; Richardson, Mary-Ann; Rodríguez-Mateos, Mariano; Jordán-Iborra, Carlota; Brew, Joe; Carmona-Torre, Francisco; Giráldez, Miriam; Laso, Ester; Gabaldón-Figueira, Juan C; Dobaño, Carlota; Moncunill, Gemma; Yuste, José R; Del Pozo, Jose L; Rabinovich, N Regina; Schöning, Verena; ... (2021). The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial. EClinicalMedicine, 32, p. 100720. Elsevier 10.1016/j.eclinm.2020.100720

Kern, Charlotte; Schöning, Verena; Chaccour, Carlos; Hammann, Felix (2021). Modeling of SARS-CoV-2 treatment effects for informed drug repurposing. Frontiers in Pharmacology, 12 Frontiers 10.3389/fphar.2021.625678

Helma, Christoph; Schöning, Verena; Drewe, Jürgen; Boss, Philipp (2021). A Comparison of Nine Machine Learning Mutagenicity Models and Their Application for Predicting Pyrrolizidine Alkaloids. Frontiers in Pharmacology, 12, p. 708050. Frontiers 10.3389/fphar.2021.708050

Provide Feedback